JP2008531719A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531719A5 JP2008531719A5 JP2007558223A JP2007558223A JP2008531719A5 JP 2008531719 A5 JP2008531719 A5 JP 2008531719A5 JP 2007558223 A JP2007558223 A JP 2007558223A JP 2007558223 A JP2007558223 A JP 2007558223A JP 2008531719 A5 JP2008531719 A5 JP 2008531719A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- seq
- amino acids
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65778905P | 2005-03-02 | 2005-03-02 | |
| PCT/US2006/007441 WO2006094134A2 (en) | 2005-03-02 | 2006-03-02 | Kim-1 antibodies for treatment of th2-mediated conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012073852A Division JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531719A JP2008531719A (ja) | 2008-08-14 |
| JP2008531719A5 true JP2008531719A5 (https=) | 2009-03-26 |
Family
ID=36648475
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558223A Withdrawn JP2008531719A (ja) | 2005-03-02 | 2006-03-02 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
| JP2012073852A Pending JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012073852A Pending JP2012131825A (ja) | 2005-03-02 | 2012-03-28 | Ｔｈ２介在性状態の治療のためのＫＩＭ−１抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8206705B2 (https=) |
| EP (2) | EP2251037B1 (https=) |
| JP (2) | JP2008531719A (https=) |
| KR (1) | KR101213894B1 (https=) |
| CN (2) | CN101166542A (https=) |
| AT (1) | ATE478707T1 (https=) |
| AU (2) | AU2006218489B2 (https=) |
| BR (1) | BRPI0608254A2 (https=) |
| CA (1) | CA2599967C (https=) |
| DE (1) | DE602006016413D1 (https=) |
| IL (1) | IL185653A (https=) |
| NZ (1) | NZ562045A (https=) |
| WO (1) | WO2006094134A2 (https=) |
| ZA (1) | ZA200708372B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008064031A2 (en) * | 2006-11-13 | 2008-05-29 | Government Of The United States, As Represented Bythe Secretary Of The Department Of Health And Human Services | Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| WO2012145746A1 (en) | 2011-04-21 | 2012-10-26 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for the treatment of neuromyelitis optica |
| KR20180083868A (ko) | 2015-10-30 | 2018-07-23 | 알레타 바이오쎄라퓨틱스, 인크. | 종양 형질도입용 조성물 및 방법 |
| JP7115982B2 (ja) | 2015-10-30 | 2022-08-09 | アレタ・バイオセラピューティクス・インコーポレイテッド | 癌の治療のための組成物及び方法 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DK0678122T3 (da) | 1993-01-12 | 2000-03-06 | Biogen Inc | Rekombinante anti-VLA4 antistofmolekyler |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5622861A (en) | 1994-08-05 | 1997-04-22 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA encoding hepatitis A virus receptor |
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| DE19541844C1 (de) | 1995-11-09 | 1997-07-24 | Gsf Forschungszentrum Umwelt | Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung |
| US6165733A (en) | 1996-05-23 | 2000-12-26 | Chiron Corporation | γ II adaptin |
| WO1997044460A1 (en) | 1996-05-24 | 1997-11-27 | Biogen, Inc. | Modulators of tissue regeneration |
| JP2001503271A (ja) | 1996-11-01 | 2001-03-13 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | ヒト粘膜アドレシン細胞接着分子―１（ＭＡｄＣＡＭ―１）およびそのスプライス変異体 |
| EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
| EP0942925B1 (en) | 1996-12-06 | 2006-11-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1 beta converting enzyme |
| WO1999037682A2 (en) | 1998-01-23 | 1999-07-29 | F.Hoffmann-La Roche Ag | Antibodies against human il-12 |
| EP1062949A4 (en) | 1998-03-11 | 2002-10-09 | Mitsubishi Pharma Corp | IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |
| US6228642B1 (en) | 1998-10-05 | 2001-05-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression |
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| DE60137934D1 (de) | 2000-06-16 | 2009-04-23 | Biogen Idec Inc | Renale regulatorische elemente und deren verwendung |
| EP1401869B1 (en) | 2001-06-01 | 2007-12-26 | Biogen Idec MA Inc. | Molecules and methods for inhibiting shedding of kim-1 |
| US7838220B2 (en) | 2001-06-29 | 2010-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | T cell regulatory genes associated with immune disease |
| EP1406653A4 (en) | 2001-06-29 | 2005-05-04 | Univ Leland Stanford Junior | T CELL REGULATION GENES AND METHOD OF USE THEREOF |
| CA2459219A1 (en) | 2001-09-17 | 2003-03-27 | Protein Design Labs, Inc. | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| WO2003042661A2 (en) | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| US7687454B2 (en) | 2001-12-03 | 2010-03-30 | The University Of British Columbia | Effectors of innate immunity determination |
| AU2003303082B2 (en) | 2002-01-30 | 2009-07-02 | Dana-Farber Cancer Institute, Inc. | Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| CA2479732A1 (en) | 2002-03-19 | 2003-10-02 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| GB0215509D0 (en) | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
| DK1585546T3 (da) | 2002-12-30 | 2008-12-08 | Biogen Idec Inc | KIM- 1- Antagonister og Brug til at Modulere Immunsystem |
| DK1613750T3 (en) | 2003-03-19 | 2016-01-18 | Amgen Fremont Inc | ANTIBODIES TO T CELL AND MUCINDO immunoglobulin-binding domain 1 (TIM-1) antigen and uses thereof |
| US20050119210A1 (en) | 2003-05-20 | 2005-06-02 | Xiaobing Be | Compositions and methods for diagnosing and treating cancers |
| TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| AU2005231685A1 (en) | 2004-03-24 | 2005-10-20 | Telos Pharmaceuticals Llc | Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| US8025557B2 (en) | 2009-02-27 | 2011-09-27 | Illinois Tool Works Inc. | Sanding clay |
-
2006
- 2006-03-02 EP EP10173620.5A patent/EP2251037B1/en not_active Expired - Lifetime
- 2006-03-02 JP JP2007558223A patent/JP2008531719A/ja not_active Withdrawn
- 2006-03-02 CN CNA2006800139893A patent/CN101166542A/zh active Pending
- 2006-03-02 EP EP06736714A patent/EP1865985B1/en not_active Expired - Lifetime
- 2006-03-02 WO PCT/US2006/007441 patent/WO2006094134A2/en not_active Ceased
- 2006-03-02 AU AU2006218489A patent/AU2006218489B2/en not_active Ceased
- 2006-03-02 CA CA2599967A patent/CA2599967C/en not_active Expired - Fee Related
- 2006-03-02 DE DE602006016413T patent/DE602006016413D1/de not_active Expired - Lifetime
- 2006-03-02 KR KR1020077022608A patent/KR101213894B1/ko not_active Expired - Fee Related
- 2006-03-02 CN CN201410043208.1A patent/CN103751780A/zh active Pending
- 2006-03-02 NZ NZ562045A patent/NZ562045A/en not_active IP Right Cessation
- 2006-03-02 US US11/817,638 patent/US8206705B2/en not_active Expired - Fee Related
- 2006-03-02 BR BRPI0608254-8A patent/BRPI0608254A2/pt not_active IP Right Cessation
- 2006-03-02 AT AT06736714T patent/ATE478707T1/de not_active IP Right Cessation
-
2007
- 2007-09-02 IL IL185653A patent/IL185653A/en not_active IP Right Cessation
- 2007-10-01 ZA ZA200708372A patent/ZA200708372B/xx unknown
-
2011
- 2011-05-24 AU AU2011202405A patent/AU2011202405B2/en not_active Ceased
-
2012
- 2012-03-28 JP JP2012073852A patent/JP2012131825A/ja active Pending
- 2012-04-04 US US13/439,413 patent/US20130089539A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009511480A5 (https=) | ||
| JP2024075713A5 (https=) | ||
| FI3569620T3 (fi) | Ihmisen cgrp-reseptoria sitovat vasta-aineet | |
| JP2013518912A5 (https=) | ||
| JP2010512320A5 (https=) | ||
| JP2021038246A (ja) | 分泌様免疫グロブリンを含む組成物 | |
| JP2006506333A5 (https=) | ||
| JP2023081303A5 (https=) | ||
| JP2009539841A5 (https=) | ||
| NO20051048L (no) | Terapeutisk humant anti-IL-1R1 monoklonalt antistoff | |
| JP2006522830A5 (https=) | ||
| JP2006519762A5 (https=) | ||
| JP2010526028A5 (https=) | ||
| RU2012141556A (ru) | Способы и композиции для лечения болезни дего | |
| HRP20190008T4 (hr) | Prevencija i liječenje sinukleinopatske i amiloidogene bolesti | |
| JP2012121878A5 (https=) | ||
| JP2011502137A5 (https=) | ||
| JP2016509585A5 (https=) | ||
| JP2011207882A5 (https=) | ||
| JP2017113019A5 (https=) | ||
| JP2021524231A5 (https=) | ||
| JP2005505256A5 (https=) | ||
| JP2012102122A5 (https=) | ||
| JP2012504602A5 (https=) | ||
| AU2021373703A1 (en) | Antigen-binding molecules that bind to porphyromonas gingivalis |